¿¬¼ö°­ÁÂ
2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30

2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30
±³À°ÀÏÀÚ : 2024-03-30
±³À°Àå¼Ò : ´ëÀü¾¾Á¨ÀÇ·áÀç´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦

±³À°ÁÖÁ¦ : 2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ±Ù¿¬±¸È¸

´ã´çÀÚ : Çѹμö
¿¬¶ôó : 031-981-2764

À̸ÞÀÏ : daonics@naver.com

±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í Àü°øÀÇ ¹× ±âŸÀÇ·áÁø 2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:00~09:40 Malignant Hyperthermia: A Practical Guide in Korea ÀÓº´°Ç(°í·ÁÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:40~10:20 Anesthesia and Environment ¿À¾Æ¿µ(¼­¿ïÀÇ´ë)

ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:20~10:35 Break ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:35~11:00 Efficacy and Safety of Sugammadex in Children À̼ö¹Î(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:00~11:25 Sugammadex in Pregnant Women and Women of Childbearing Age ÀÌÁØÈ£(ÀüºÏÀÇ´ë)

Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:25~11:35 Q&A ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:35~12:00 Neuromuscular Blockade and Its Reversal in Geriatric Population ¼ºÅÂÀ±(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:00~12:25 Neuromuscular Blockade and Its Reversal in Musculoskeletal Disorder ÇÑÁö¿ø(Áß¾ÓÀÇ´ë)

Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:25~12:35 Q&A ()

½Ä»ç 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:35~13:35 Lunch ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 13:35~14:05 Good Clinical Research Practice (GCRP) in Neuromuscular Research ±¸Ã¢ÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:05~14:35 Common Flaws in Neuromuscular Research Á¤±âÅÂ(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:35~15:05 Unmet needs in Neuromuscular Research ÀÌ»ó¼®(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:05~15:20 Q&A ()

ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:20~15:35 Break ()

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:35~15:50 Resistance or Tachyphylaxis to Rocuronium õº¸¸§(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:50~16:05 Analysis of characteristics of patients whose sugammadex claims were denied by the Auto Insurance Claims Review Department. Á¶¼ö¿¬(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:05~16:20 Response of adductor longus muscle during obturator nerve block under deep NMB ÇÏÀº±³(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:20~16:35 Comparison of effects of sugammadex administration timing on the success rate of neuromuscular monitoring before extubation and recovery profile in patients undergoing general anesthesia À̱Կø(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:35~16:50 Rocuronium induced anaphylaxis in robotic hysterectomy À̵¿±Ù(Ãæ³²ÀÇ´ë)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) Á¦4ȸ °­µ¿¼º½Éº´¿ø ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á "Äڷγª19 ½Ã´ëÀÇ ¼Ò¾Æû¼Ò³â°ú ¸¸¼ºÁúȯ Áø·á ..

(¿Â¶óÀÎ) Á¦4ȸ °­µ¿¼º½Éº´¿ø ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á "Äڷγª19 ½Ã´ëÀÇ ¼Ò¾Æû¼Ò³â°ú ¸¸¼ºÁúȯ Áø·á ¹× »ó´ã" : 2021-06-26 ±³À°ÀÏÀÚ : 2021-06-26 ±³À°Àå¼Ò : ¿Â

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,374 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÇǺΰúÀÇ»çȸ ⸳ 20Áֳ⠱â³äÇà»ç ¹× Á¦21ȸ Ãß°èÇмú´ëȸ : 2018-11-04

±³À°ÀÏÀÚ : 2018-11-04 ±³À°Àå¼Ò : ±×·£µåÈúÆ°È£ÅÚ(È«Àºµ¿) ÄÁº¥¼Ç¼¾ÅÍ ¿Ü ±³À°ÁÖÁ¦ : ´ëÇÑÇǺΰúÀÇ»çȸ ⸳ 20Áֳ⠱â³äÇà»ç ¹× Á¦21ȸ Ãß°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 14,382 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,046 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-16

±³À°ÀÏÀÚ : 2024-03-16 ±³À°Àå¼Ò : ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,143 , ´ñ±Û¼ö : 0

[´ë±¸] Á¦27Â÷ ´ëÇѽÉÀåÇÐȸ ´ë±¸°æºÏÁöȸ ÀÓ»ó½ÉÀåÇÐ ¿¬¼ö°­Á : 2024-03-24

±³À°ÀÏÀÚ : 2024-03-24 ±³À°Àå¼Ò : ´ë±¸ ÀÎÅÍºÒ°í ¸¸Ã̵¿ ÄÁº¥¼ÇȦ 2Ãþ ±³À°ÁÖÁ¦ : Á¦27Â÷ ´ëÇѽÉÀåÇÐȸ ´ë±¸°æºÏÁöȸ ÀÓ»ó½ÉÀåÇÐ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ ½ÃÇà±â

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,169 , ´ñ±Û¼ö : 0